Galderma: Switzerland's Botox Leader
The dermatology company's market value has doubled since its 2024 IPO. Despite ongoing scandals, botulinum toxin injections are projected to generate $13 billion this year.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading